Review



mir 23b 3p mimic  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    MedChemExpress mir 23b 3p mimic
    Mir 23b 3p Mimic, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mir+23b+3p+mimic/MicroRNA+Mimic+Negative+Control/pm41804264-202-2-6
    Average 95 stars, based on 30 article reviews
    mir 23b 3p mimic - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: Exosomes from macrophages intervened by Jiedu Yangxin decoction mediated endothelial-to-mesenchymal transition to improve myocardial fibrosis after myocardial infarction.
    Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 82474331 Abstract Background and Purpose: Myocardial fibrosis, a critical pathological feature in myocardial infarction (MI) associated with adverse outcomes.. Endothelial-tomesenchymal transition (EndMT) emerges as a central driver of fibrosis, regulated by macrophage polarization and exosomal microRNAs (miRNAs).. This study elucidates the anti-fibrotic mechanism of Jiedu Yangxin Decoction (JDYX), a Traditional Chinese Medicine, investigating regulation of macrophage-derived exosomes and suppression of EndMT in post-myocardial infarction (MI) cardiac remodelling.



    Similar Products

    mir 23b 3p mimic  (MedChemExpress)
    95
    MedChemExpress mir 23b 3p mimic
    Mir 23b 3p Mimic, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mir+23b+3p+mimic/MicroRNA+Mimic+Negative+Control/pm41804264-202-2-6
    Average 95 stars, based on 1 article reviews
    mir 23b 3p mimic - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    mirna mimics for mmu/hsa-mir-23b-3p  (Gene Design Inc)
    90
    Gene Design Inc mirna mimics for mmu/hsa-mir-23b-3p
    Mirna Mimics For Mmu/Hsa Mir 23b 3p, supplied by Gene Design Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mir+23b+3p+mimic/mirnas/pm40596573-63-4-11
    Average 90 stars, based on 1 article reviews
    mirna mimics for mmu/hsa-mir-23b-3p - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mir-23b-3p mimics  (Ribobio co)
    90
    Ribobio co mir-23b-3p mimics
    Mir 23b 3p Mimics, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mir+23b+3p+mimic/mir+23a+mimic/pm40483528-65-1-15
    Average 90 stars, based on 1 article reviews
    mir-23b-3p mimics - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mir-23b-3p mimic  (Sangon Biotech)
    90
    Sangon Biotech mir-23b-3p mimic
    Mir 23b 3p Mimic, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mir+23b+3p+mimic/mir+23a+mimics/pm38739483-28-1-10
    Average 90 stars, based on 1 article reviews
    mir-23b-3p mimic - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mir-23b-3p mimic  (Ribobio co)
    90
    Ribobio co mir-23b-3p mimic
    A AGO2 RNA-binding protein immunoprecipitation. All data are shown as the mean ± SD. *** P < 0.001 compared to IgG. B circRNA pull-down assay. 0013561 is referred to as hsa_circ_0013561. ** P < 0.01 compared to negative control (NC) probe. C The luciferase activity of HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with different miRNA mimics or control (NC) mimics. D Prediction of <t>miR-23b-3p</t> binding sites in hsa_circ_0013561. The mutated (Mut) version of hsa_circ_0013561 was constructed. E Relative luciferase activity was tested in HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. F Prediction of miR-23b-3p binding sites within the 3’ UTR of ANXA2. The Mut version of ANXA2 3’-UTR is shown. G Relative luciferase activity was tested in HEK293T cells with ANXA2 3’ UTR-Wt or ANXA2 3’ UTR-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. H Bioinformatics analysis ( http://www.oncolnc.org/ ) showed the survival rate between OC patients with high and low ANXA2 expression.
    Mir 23b 3p Mimic, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mir+23b+3p+mimic/mir+23a+mimic/pmc10794140-35-10-51
    Average 90 stars, based on 1 article reviews
    mir-23b-3p mimic - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mir-23b-3p mimics  (Shanghai GenePharma)
    90
    Shanghai GenePharma mir-23b-3p mimics
    A AGO2 RNA-binding protein immunoprecipitation. All data are shown as the mean ± SD. *** P < 0.001 compared to IgG. B circRNA pull-down assay. 0013561 is referred to as hsa_circ_0013561. ** P < 0.01 compared to negative control (NC) probe. C The luciferase activity of HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with different miRNA mimics or control (NC) mimics. D Prediction of <t>miR-23b-3p</t> binding sites in hsa_circ_0013561. The mutated (Mut) version of hsa_circ_0013561 was constructed. E Relative luciferase activity was tested in HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. F Prediction of miR-23b-3p binding sites within the 3’ UTR of ANXA2. The Mut version of ANXA2 3’-UTR is shown. G Relative luciferase activity was tested in HEK293T cells with ANXA2 3’ UTR-Wt or ANXA2 3’ UTR-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. H Bioinformatics analysis ( http://www.oncolnc.org/ ) showed the survival rate between OC patients with high and low ANXA2 expression.
    Mir 23b 3p Mimics, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mir+23b+3p+mimic/mir+23a+inhibitor/pm36538848-78-30-38
    Average 90 stars, based on 1 article reviews
    mir-23b-3p mimics - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    mir-23b-3p mimic  (Shanghai GenePharma)
    90
    Shanghai GenePharma mir-23b-3p mimic
    A AGO2 RNA-binding protein immunoprecipitation. All data are shown as the mean ± SD. *** P < 0.001 compared to IgG. B circRNA pull-down assay. 0013561 is referred to as hsa_circ_0013561. ** P < 0.01 compared to negative control (NC) probe. C The luciferase activity of HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with different miRNA mimics or control (NC) mimics. D Prediction of <t>miR-23b-3p</t> binding sites in hsa_circ_0013561. The mutated (Mut) version of hsa_circ_0013561 was constructed. E Relative luciferase activity was tested in HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. F Prediction of miR-23b-3p binding sites within the 3’ UTR of ANXA2. The Mut version of ANXA2 3’-UTR is shown. G Relative luciferase activity was tested in HEK293T cells with ANXA2 3’ UTR-Wt or ANXA2 3’ UTR-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. H Bioinformatics analysis ( http://www.oncolnc.org/ ) showed the survival rate between OC patients with high and low ANXA2 expression.
    Mir 23b 3p Mimic, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mir+23b+3p+mimic/mir+23a+inhibitor/pm36214997-46-20-24
    Average 90 stars, based on 1 article reviews
    mir-23b-3p mimic - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A AGO2 RNA-binding protein immunoprecipitation. All data are shown as the mean ± SD. *** P < 0.001 compared to IgG. B circRNA pull-down assay. 0013561 is referred to as hsa_circ_0013561. ** P < 0.01 compared to negative control (NC) probe. C The luciferase activity of HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with different miRNA mimics or control (NC) mimics. D Prediction of miR-23b-3p binding sites in hsa_circ_0013561. The mutated (Mut) version of hsa_circ_0013561 was constructed. E Relative luciferase activity was tested in HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. F Prediction of miR-23b-3p binding sites within the 3’ UTR of ANXA2. The Mut version of ANXA2 3’-UTR is shown. G Relative luciferase activity was tested in HEK293T cells with ANXA2 3’ UTR-Wt or ANXA2 3’ UTR-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. H Bioinformatics analysis ( http://www.oncolnc.org/ ) showed the survival rate between OC patients with high and low ANXA2 expression.

    Journal: Cancer Gene Therapy

    Article Title: Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer

    doi: 10.1038/s41417-023-00686-z

    Figure Lengend Snippet: A AGO2 RNA-binding protein immunoprecipitation. All data are shown as the mean ± SD. *** P < 0.001 compared to IgG. B circRNA pull-down assay. 0013561 is referred to as hsa_circ_0013561. ** P < 0.01 compared to negative control (NC) probe. C The luciferase activity of HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with different miRNA mimics or control (NC) mimics. D Prediction of miR-23b-3p binding sites in hsa_circ_0013561. The mutated (Mut) version of hsa_circ_0013561 was constructed. E Relative luciferase activity was tested in HEK293T cells with hsa_circ_0013561-Wt or hsa_circ_0013561-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. F Prediction of miR-23b-3p binding sites within the 3’ UTR of ANXA2. The Mut version of ANXA2 3’-UTR is shown. G Relative luciferase activity was tested in HEK293T cells with ANXA2 3’ UTR-Wt or ANXA2 3’ UTR-Mut co-transfected with miR-23b-3p mimics or NC mimics, *** P < 0.001. H Bioinformatics analysis ( http://www.oncolnc.org/ ) showed the survival rate between OC patients with high and low ANXA2 expression.

    Article Snippet: MiR-23b-3p inhibitor (final small interfering RNA (siRNA) concentration: 20 nM), miR-23b-3p mimic (microRNA (miRNA) mimic: 100 nM, mature miRNA for miR-23b-3p: 5′-UAGCAGCACGUAAAUAUUGGCG-3′), hsa_circ_0013561 silencing vector (si-circ-0013561, siRNA concentration 20 nM, siRNA for circ-0013561: 5′-TTTAGGTCTTGGGCTTGCC-3′), and ANXA2 overexpression vector (ANXA2, final concentration: 20 nM, cDNA sequence cloned into pcDNA3.1 vector) purchased from RiboBio (Guangzhou, China) were used for transfection with Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA, USA).

    Techniques: RNA Binding Assay, Immunoprecipitation, Pull Down Assay, Negative Control, Luciferase, Activity Assay, Transfection, Binding Assay, Construct, Expressing

    A – F A series of rescue experiments demonstrated the expression of hsa_circ_0013561, miR-23b-3p, and ANXA2 in SKOV3 and A2780 after transfection with si-circ-0013561, miR-23b-3p inhibitor, and ANXA2 overexpression vector singly or combined, measured by RT-qPCR, * P < 0.05, ** P < 0.01, *** P < 0.001 vs. NC; ## P < 0.01, ### P < 0.001 vs. si-circ-0013561.

    Journal: Cancer Gene Therapy

    Article Title: Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer

    doi: 10.1038/s41417-023-00686-z

    Figure Lengend Snippet: A – F A series of rescue experiments demonstrated the expression of hsa_circ_0013561, miR-23b-3p, and ANXA2 in SKOV3 and A2780 after transfection with si-circ-0013561, miR-23b-3p inhibitor, and ANXA2 overexpression vector singly or combined, measured by RT-qPCR, * P < 0.05, ** P < 0.01, *** P < 0.001 vs. NC; ## P < 0.01, ### P < 0.001 vs. si-circ-0013561.

    Article Snippet: MiR-23b-3p inhibitor (final small interfering RNA (siRNA) concentration: 20 nM), miR-23b-3p mimic (microRNA (miRNA) mimic: 100 nM, mature miRNA for miR-23b-3p: 5′-UAGCAGCACGUAAAUAUUGGCG-3′), hsa_circ_0013561 silencing vector (si-circ-0013561, siRNA concentration 20 nM, siRNA for circ-0013561: 5′-TTTAGGTCTTGGGCTTGCC-3′), and ANXA2 overexpression vector (ANXA2, final concentration: 20 nM, cDNA sequence cloned into pcDNA3.1 vector) purchased from RiboBio (Guangzhou, China) were used for transfection with Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA, USA).

    Techniques: Expressing, Transfection, Over Expression, Plasmid Preparation, Quantitative RT-PCR

    A – D The expression of miR-23b-3p and ANXA2 in SKOV3 and A2780 detected by RT-qPCR, ** P < 0.01, *** P < 0.001 vs. NC; ### P < 0.001 vs. miR-23b-3p mimic. E – G The proliferation capacity of SKOV3 and A2780 detected by EdU assay, * P < 0.05, ** P < 0.01, *** P < 0.001 vs. NC; ## P < 0.01 vs. miR-23b-3p mimic. H – J The invasion and migration capacity of SKOV3 and A2780 detected by transwell assay, ** P < 0.01, *** P < 0.001 vs. NC; ### P < 0.001 vs. miR-23b-3p mimic.

    Journal: Cancer Gene Therapy

    Article Title: Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer

    doi: 10.1038/s41417-023-00686-z

    Figure Lengend Snippet: A – D The expression of miR-23b-3p and ANXA2 in SKOV3 and A2780 detected by RT-qPCR, ** P < 0.01, *** P < 0.001 vs. NC; ### P < 0.001 vs. miR-23b-3p mimic. E – G The proliferation capacity of SKOV3 and A2780 detected by EdU assay, * P < 0.05, ** P < 0.01, *** P < 0.001 vs. NC; ## P < 0.01 vs. miR-23b-3p mimic. H – J The invasion and migration capacity of SKOV3 and A2780 detected by transwell assay, ** P < 0.01, *** P < 0.001 vs. NC; ### P < 0.001 vs. miR-23b-3p mimic.

    Article Snippet: MiR-23b-3p inhibitor (final small interfering RNA (siRNA) concentration: 20 nM), miR-23b-3p mimic (microRNA (miRNA) mimic: 100 nM, mature miRNA for miR-23b-3p: 5′-UAGCAGCACGUAAAUAUUGGCG-3′), hsa_circ_0013561 silencing vector (si-circ-0013561, siRNA concentration 20 nM, siRNA for circ-0013561: 5′-TTTAGGTCTTGGGCTTGCC-3′), and ANXA2 overexpression vector (ANXA2, final concentration: 20 nM, cDNA sequence cloned into pcDNA3.1 vector) purchased from RiboBio (Guangzhou, China) were used for transfection with Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA, USA).

    Techniques: Expressing, Quantitative RT-PCR, EdU Assay, Migration, Transwell Assay